We are a top site for some of the most advanced radiopharmaceutical trials in the world. Explore innovative imaging opportunities and potentially life-saving therapies for diseases like prostate cancer, pancreatic cancer, small cell lung cancer, and many others. Clinical trial patients can expect the same exceptional care and attention as our standard treatment patients.
- Access to radiopharmaceutical imaging agents
- Access to radiopharmaceutical therapies
- Highest level of clinical safety practices
- Highest quality patient experience
- World-class Theranostics experts
- Complimentary on-site valet parking
BAMF Health is working every day to conduct additional clinical trials to improve disease management using molecular imaging and molecularly targeted radiation therapy.
Please fill out this form if you would like to receive updates about BAMF Health clinical trials that match your interests. We will contact you with information about opportunities to participate.
Clinical Trial Updates
Calyx / Invicro Forges a Strategic Collaboration with BAMF Health to Accelerate Clinical Translation of Radioligand Therapies and Immuno-Oncology Agents
This partnership with enhance and speed up the therapy development process.
June 7, 2024
BAMF Health Completes First-in-Human Imaging Using a Novel Radiopharmaceutical for Pancreatic Cancer
The phase 1 clinical trial tests feasibility of NMK89 for the imaging of pancreatic cancer.
April 10, 2024
BAMF Health and Corewell Health Partner on Clinical Trial to Test Targeted Radiation Therapy for Cancer Patients
BAMF Health and Corewell Health are partnering on their first clinical trial to investigate a new targeted liquid radiation therapy for cancer patients whose chemotherapy treatments have been unsuccessful.
March 4, 2024